Literature DB >> 22737969

Intestinal permeability of cyclic peptides: common key backbone motifs identified.

Johannes G Beck1, Jayanta Chatterjee, Burkhardt Laufer, Marelli Udaya Kiran, Andreas O Frank, Stefanie Neubauer, Oded Ovadia, Sarit Greenberg, Chaim Gilon, Amnon Hoffman, Horst Kessler.   

Abstract

Insufficient oral bioavailability is considered as a key limitation for the widespread development of peptides as therapeutics. While the oral bioavailability of small organic compounds is often estimated from simple rules, similar rules do not apply to peptides, and even the high oral bioavailability that is described for a small number of peptides is not well understood. Here we present two highly Caco-2 permeable template structures based on a library of 54 cyclo(-D-Ala-Ala(5)-) peptides with different N-methylation patterns. The first (all-trans) template structure possesses two β-turns of type II along Ala(6)-D-Ala(1) and Ala(3)-Ala(4) and is only found for one peptide with two N-methyl groups at D-Ala(1) and Ala(6) [(NMe(1,6)]. The second (single-cis) template possesses a characteristic cis peptide bond preceding Ala(5), which results in type VI β-turn geometry along Ala(4)-Ala(5). Although the second template structure is found in seven peptides carrying N-methyl groups on Ala(5), high Caco-2 permeability is only found for a subgroup of two of them [NMe(1,5) and NMe(1,2,4,5)], suggesting that N-methylation of D-Ala(1) is a prerequisite for high permeability of the second template structure. The structural similarity of the second template structure with the orally bioavailable somatostatin analog cyclo(-Pro-Phe-NMe-D-Trp-NMe-Lys-Thr-NMe-Phe-), and the striking resemblance with both β-turns of the orally bioavailable peptide cyclosporine A, suggests that the introduction of bioactive sequences on the highly Caco-2 permeable templates may result in potent orally bioavailable drug candidates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22737969     DOI: 10.1021/ja303200d

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  27 in total

1.  EPSA: A Novel Supercritical Fluid Chromatography Technique Enabling the Design of Permeable Cyclic Peptides.

Authors:  Gilles H Goetz; Laurence Philippe; Michael J Shapiro
Journal:  ACS Med Chem Lett       Date:  2014-08-04       Impact factor: 4.345

Review 2.  Strategic approaches to optimizing peptide ADME properties.

Authors:  Li Di
Journal:  AAPS J       Date:  2014-11-04       Impact factor: 4.009

3.  Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance().

Authors:  Arthur C Rand; Siegfried S F Leung; Heather Eng; Charles J Rotter; Raman Sharma; Amit S Kalgutkar; Yizhong Zhang; Manthena V Varma; Kathleen A Farley; Bhagyashree Khunte; Chris Limberakis; David A Price; Spiros Liras; Alan M Mathiowetz; Matthew P Jacobson; R Scott Lokey
Journal:  Medchemcomm       Date:  2012-10       Impact factor: 3.597

4.  Cyclic Penta- and Hexaleucine Peptides without N-Methylation Are Orally Absorbed.

Authors:  Timothy A Hill; Rink-Jan Lohman; Huy N Hoang; Daniel S Nielsen; Conor C G Scully; W Mei Kok; Ligong Liu; Andrew J Lucke; Martin J Stoermer; Christina I Schroeder; Stephanie Chaousis; Barbara Colless; Paul V Bernhardt; David J Edmonds; David A Griffith; Charles J Rotter; Roger B Ruggeri; David A Price; Spiros Liras; David J Craik; David P Fairlie
Journal:  ACS Med Chem Lett       Date:  2014-08-04       Impact factor: 4.345

5.  Predicting bioactive conformations and binding modes of macrocycles.

Authors:  Andrew Anighoro; Antonio de la Vega de León; Jürgen Bajorath
Journal:  J Comput Aided Mol Des       Date:  2016-09-21       Impact factor: 3.686

Review 6.  Novel approaches to the design of bioavailable melanotropins.

Authors:  Yang Zhou; Minying Cai
Journal:  Expert Opin Drug Discov       Date:  2017-07-12       Impact factor: 6.098

Review 7.  Peptide-Based Therapeutics for Oncology.

Authors:  Elizaveta Fisher; Kirill Pavlenko; Alexander Vlasov; Galina Ramenskaya
Journal:  Pharmaceut Med       Date:  2019-02

8.  In Search of the Optimal Macrocyclization Site for Neurotensin.

Authors:  Marc Sousbie; Élie Besserer-Offroy; Rebecca L Brouillette; Jean-Michel Longpré; Richard Leduc; Philippe Sarret; Éric Marsault
Journal:  ACS Med Chem Lett       Date:  2018-01-29       Impact factor: 4.345

9.  Peptide macrocyclization catalyzed by a prolyl oligopeptidase involved in α-amanitin biosynthesis.

Authors:  Hong Luo; Sung-Yong Hong; R Michael Sgambelluri; Evan Angelos; Xuan Li; Jonathan D Walton
Journal:  Chem Biol       Date:  2014-12-04

10.  Systematic Backbone Conformational Constraints on a Cyclic Melanotropin Ligand Leads to Highly Selective Ligands for Multiple Melanocortin Receptors.

Authors:  Minying Cai; Udaya Kiran Marelli; Jennifer Bao; Johannes G Beck; Florian Opperer; Florian Rechenmacher; Kaitlyn R McLeod; Morgan R Zingsheim; Lucas Doedens; Horst Kessler; Victor J Hruby
Journal:  J Med Chem       Date:  2015-08-11       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.